World News

Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment...

Ogkologos - 12 Μαρτίου, 2026

Rare Cancers Forum 2026: ESMO Leads European Efforts to Turn Evidence...

Ogkologos - 11 Μαρτίου, 2026

FDA Grants Traditional Approval to Encorafenib for mCRC with a BRAF...

Ogkologos - 11 Μαρτίου, 2026

In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in...

Ogkologos - 10 Μαρτίου, 2026

Adjuvant Imatinib Prolongs RFS and OS in Patients with Resected GIST...

Ogkologos - 10 Μαρτίου, 2026

Immune Pathways Help Identify Patients with Cancer and HIV Most Likely...

Ogkologos - 9 Μαρτίου, 2026

Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities

Ogkologos - 6 Μαρτίου, 2026

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent...

Ogkologos - 5 Μαρτίου, 2026

FDA Approves Acalabrutinib with Venetoclax for CLL or SLL

Ogkologos - 4 Μαρτίου, 2026

No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with...

Ogkologos - 3 Μαρτίου, 2026

1...232425...432 Σελίδα 24 από 432

MOST POPULAR

Opinion: ‘Let’s not be short-sighted – the UK’s medical research charities...

24 Σεπτεμβρίου, 2020

Worried Cancer Patients Face Delayed Treatment Because Of Pandemic

1 Απριλίου, 2020

Why is Colorectal Cancer Rising Rapidly among Young Adults?

5 Νοεμβρίου, 2020

Coping with Grief: An Interview with Author Rebecca Munn

28 Σεπτεμβρίου, 2020

Φόρτωση περισσοτέρων

Induction ICI Combination Followed by CRT Is An Effective Bladder-Sparing Treatment...

Rare Cancers Forum 2026: ESMO Leads European Efforts to Turn Evidence...

FDA Grants Traditional Approval to Encorafenib for mCRC with a BRAF...

In Memory of Hernán Cortés-Funes: Former ESMO President and Pioneer in...

Adjuvant Imatinib Prolongs RFS and OS in Patients with Resected GIST...

Immune Pathways Help Identify Patients with Cancer and HIV Most Likely...

Shaping Future Oncology Leaders: ESMO Broadens Its Career Development Opportunities

Adding Hormone Therapy to PORT Might Not Benefit Patients with Recurrent...

FDA Approves Acalabrutinib with Venetoclax for CLL or SLL

No OS Improvement with CDK4/6 Inhibitors Used in First- Compared with...

MOST POPULAR

Opinion: ‘Let’s not be short-sighted – the UK’s medical research charities...

Worried Cancer Patients Face Delayed Treatment Because Of Pandemic

Why is Colorectal Cancer Rising Rapidly among Young Adults?

Coping with Grief: An Interview with Author Rebecca Munn

HOT NEWS

Azacitidine-Venetoclax Prolongs EFS Over Induction Chemotherapy Among Induction-Eligible Patients with AML

A Combination of Trifluridine-Tipiracil Plus Bevacizumab Results in Longer Overall Survival...

The Combination of Nivolumab and Cabozantinib Provides a New First-Line Treatment...

EMA Recommends Extension of Therapeutic Indications for Atezolizumab

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ